Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0002736 (amyotrophic lateral sclerosis)
 19,048 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Heterocyclic ring compounds containing nitrogennitrogen bonds such as 1H-1,2,4 triazole, 2,4,6 trimethylbenzenesulfonyltriazolide and pyridazine can be completely decomposed in the molten state with mixtures of various ratios of concentrated sulphuric acid and lithium sulphate (molten ALS) flux containing a catalyst such as silver sulphate. The quantitative recovery of nitrogen in the above three compounds with the molten ALS flux decomposition system can be obtained by the Kjeldahl method.
 ...
PMID:ALS (acidic lithium sulphate) decomposition method (part iv) Kjeldahl determination of nitrogen in heterocyclic ring compounds containing nitrogennitrogen bond. 1896 91

The equilibria of a new Schiff base derived from 3,6-bis((aminoethyl)thio)pyridazine were studied spectrophotometrically with the aid of factor-analytical methods. Hard modeling program was used for determination of the acidity constants of the Schiff base in dimethylformamide (DMF)/water mixture (30:70 v/v). In this method acidity constant equations act as hard models and the score vectors obtained by decomposing of absorbance data matrix will be linear combinations of equilibrium concentrations of species that exist in the absorption matrix. Two rank annihilation factor analysis (TRAFA) was used as a standard method to investigate the accuracy of the method. The tautomerization constant, K(t), of the Schiff base solution in various DMF/water mixtures has also been determined using spectral variations of the Schiff base solutions in various volume ratios of water with the aid of evolving factor analysis (EFA) and multivariate curve resolution alternative least squares (MCR-ALS) methods. In addition the intramolecular hydrogen bonding strength and its related thermodynamic parameters have been determined using MCR-ALS and spectral variation of the Schiff base solutions in different temperatures.
 ...
PMID:Spectrophotometric determination of acidity and tautomeric constants and hydrogen bonding strength for a new Schiff base using hard modeling and multivariate curve resolution alternative least squares methods. 1918 17

The oxidation of the recently synthesized Schiff base 3,6-bis((2-aminoethyl-5-Br-salicyliden)thio)pyridazine (PABST) with hydrogen peroxide was investigated using spectrophotometric studies. The reaction rate order and observed rate constant of the oxidation reaction was obtained in the mixture of N,N-dimethylformamide (DMF):water (30:70, v/v) at pH 10 using multivariate cure resolution alternative least squares (MCR-ALS) method and rank annihilation factor analysis (RAFA). The effective parameters on the oxidation rate constant such as percents of DMF, the effect of transition metals like Cu(2+), Zn(2+), Mn(2+) and Hg(2+) and the presence of surfactants were investigated. The keto-enol equilibria in DMF:water (30:70, v/v) solution at pH 7.6 was also investigated in the presence of surfactants. At concentrations above critical micelle concentration (cmc) of cationic surfactant cetyltrimethylammonium bromide (CTAB), the keto form was the predominant species, while at concentrations above cmc of anionic surfactant sodium dodecyl sulfate (SDS), the enol form was the predominant species. The kinetic reaction order and the rate constant of tautomerization in micellar medium were obtained using MCR-ALS and RAFA. The results obtained by both the methods were in a good agreement with each other. Also the effect of different volume percents of DMF on the rate constant of tautomerization was investigated. The neutral surfactant (Triton X-100) had no effect on tautomerization equilibrium.
 ...
PMID:Investigation of oxidation and tautomerization of a recently synthesized Schiff base in micellar media using multivariate curve resolution alternative least squares and rank annihilation factor analysis methods. 1959 4

Glial glutamate transporter EAAT2 plays a major role in glutamate clearance in synaptic clefts. Several lines of evidence indicate that strategies designed to increase EAAT2 expression have potential for preventing excitotoxicity, which contributes to neuronal injury and death in neurodegenerative diseases. We previously discovered several classes of compounds that can increase EAAT2 expression through translational activation. Here, we present efficacy studies of the compound LDN/OSU-0212320, which is a pyridazine derivative from one of our lead series. In a murine model, LDN/OSU-0212320 had good potency, adequate pharmacokinetic properties, no observed toxicity at the doses examined, and low side effect/toxicity potential. Additionally, LDN/OSU-0212320 protected cultured neurons from glutamate-mediated excitotoxic injury and death via EAAT2 activation. Importantly, LDN/OSU-0212320 markedly delayed motor function decline and extended lifespan in an animal model of amyotrophic lateral sclerosis (ALS). We also found that LDN/OSU-0212320 substantially reduced mortality, neuronal death, and spontaneous recurrent seizures in a pilocarpine-induced temporal lobe epilepsy model. Moreover, our study demonstrated that LDN/OSU-0212320 treatment results in activation of PKC and subsequent Y-box-binding protein 1 (YB-1) activation, which regulates activation of EAAT2 translation. Our data indicate that the use of small molecules to enhance EAAT2 translation may be a therapeutic strategy for the treatment of neurodegenerative diseases.
...
PMID:Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection. 2456 69